6-[2-[4-(difluoromethoxy)phenyl]pyrazol-3-yl]-1-(3-ethyloxan-4-yl)pyrazolo[5,4-b]pyridine
C23H23F2N5O2 — CID 140527517
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[2-[4-(difluoromethoxy)phenyl]pyrazol-3-yl]-1-(3-ethyloxan-4-yl)pyrazolo[5,4-b]pyridine
6-[2-[4-(difluoromethoxy)phenyl]pyrazol-3-yl]-1-(3-ethyloxan-4-yl)pyrazolo[5,4-b]pyridine (PubChem CID 140527517) has the molecular formula C23H23F2N5O2 and a molecular weight of 439.47 g/mol. Its IUPAC name is 6-[2-[4-(difluoromethoxy)phenyl]pyrazol-3-yl]-1-(3-ethyloxan-4-yl)pyrazolo[5,4-b]pyridine.
Molecular Properties
| Compound Name | 6-[2-[4-(difluoromethoxy)phenyl]pyrazol-3-yl]-1-(3-ethyloxan-4-yl)pyrazolo[5,4-b]pyridine |
|---|---|
| PubChem CID | 140527517 |
| Molecular Formula | C23H23F2N5O2 |
| Molecular Weight | 439.47 g/mol |
| Exact Mass | 439.18 |
| IUPAC Name | 6-[2-[4-(difluoromethoxy)phenyl]pyrazol-3-yl]-1-(3-ethyloxan-4-yl)pyrazolo[5,4-b]pyridine |
| SMILES | CCC1COCCC1n1ncc2ccc(-c3ccnn3-c3ccc(OC(F)F)cc3)nc21 |
| InChI | InChI=1S/C23H23F2N5O2/c1-2-15-14-31-12-10-20(15)30-22-16(13-27-30)3-8-19(28-22)21-9-11-26-29(21)17-4-6-18(7-5-17)32-23(24)25/h3-9,11,13,15,20,23H,2,10,12,14H2,1H3 |
| InChIKey | OIQJJFXIICUQMO-UHFFFAOYSA-N |
| XLogP | 4.87 |
| TPSA | 66.99 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 439.47 |
| LogP ≤ 5 | 4.87 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 140527517 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.